Vanderbilt-Ingram Cancer Center

The Translational Pathology Shared Resource (TPSR) has opened an expanded laboratory on the first floor of Medical Center North, room S-1310. To celebrate the grand opening of the newly renovated space, TPSR is hosting an open house on Wednesday, May 30, from 1-3 p.m. Vanderbilt faculty and staff are invited to tour the new space, [...]

The symptoms of head and neck cancer can be subtle, so to help catch the disease in its earliest stages the Tennessee Chapter of the Head and Neck Cancer Alliance, Vanderbilt-Ingram Cancer Center, the Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Meharry Medical College and the VA Tennessee Valley Healthcare System will offer [...]

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” The grants were awarded to Jennifer Pietenpol, Ph.D., director of VICC, and the My Cancer Genome project, developed by Mia Levy, M.D., Ph.D., assistant professor of Medicine and Biomedical Informatics, and William Pao, M.D., Ph.D., [...]

Kathy Leiser first heard about Vanderbilt-Ingram Cancer Center’s lung cancer screening trial through a sponsorship ad on WPLN radio last summer. The Nashville office technology saleswoman and grandmother of three had stopped smoking in 2009, but she knew her smoking history put her at risk for lung cancer. So she enrolled in the screening trial, [...]

Individuals who are outside the “normal” range of expression for the APC gene have an increased risk of colorectal cancer, according to a study published in the January issue of Gastroenterology. Mutations in the APC (adenomatous polyposis coli) gene – and variations in the expression of the gene’s two copies (allele-specific expression) — are associated [...]

In the 40 years since President Nixon “declared war” on cancer, much progress has been made. We are screening more, catching cancers sooner, using DNA information to tailor treatment to the individual. Still, cancer is responsible for one in four deaths in the United States.

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five [...]

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and [...]

As a veteran meteorologist for WKRN Channel 2 in Nashville, Davis Nolan is an expert at diagnosing weather patterns that can create violent winds and thunderous storms. But he had no hints about the potentially deadly storms that were brewing inside his own body until a routine visit to his primary care physician led to [...]

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the winners of this year’s Susan G. Komen for the Cure Brinker Awards for Scientific Distinction. The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of [...]